Novel treatments for progressive multifocal leukoencephalopathy.
This article reviews research into novel therapies: immune checkpoint-blocking antibodies (nivolumab and pembrolizumab), allogenic BK virus-specific T cell treatment and filgrastim. Results for these therapies in small clinical trials are promising, but further research is required to assess efficacy fully.
PMID: 32730143 [PubMed - in process]
Source: British Journal of Hospital Medicine - Category: Internal Medicine Authors: Bennett KM, Fernandes PM Tags: Br J Hosp Med (Lond) Source Type: research
More News: BK Virus | Clinical Trials | Filgrastim | Hospitals | Internal Medicine | Neulasta | Neupogen | UK Health